Sign In
Vedanta demerger process to be completed in 9-12 mths
Aparna Pharma gets VAI classification for facility
Alembic Pharma Q3 net profit rises 48 pc to Rs 180 cr
Cipla eyes expansion in to US market
Interim Budget 2024: Rs 1,000-cr outlay for bulk drug parks
Aurobindo Pharma shares down more than 6% amid US FDA inspection
Sun Pharma posts 16.5% rise in Q3 net profit, declares dividend of Rs 8.50/share
Moderna invests in development of mRNA vax
Chinna Jeeyar Swamy inaugurates Anantha Rehabilitation Center
Healthcare, pharma sectors catching up with GenAI
India’s coronary drug-eluting stents mkt to register 4% CAGR by 2033: Report
Indian Immunologicals launches India's 1st indigenous Hepatitis A vax
